Vector Responds to HHS Call for Peptide Regulation
An Unexpected Turn in the Peptide Arena Whew, talk about a curveball in the therapeutics world. When U.S. Health and Human Services Secretary Robert F. Kennedy Jr. hit the airwaves on October 20, 2026, and talked about creating a regulated peptide marketplace, heads across the industry snapped to attention. Naturally, Vector Science and Therapeutics Corp. (TSXV: PAIN)...
Continue Reading